From: NR3C1 variants and glucocorticoid response in childhood nephrotic syndrome in North India
Side effects | SSNS group | SRNS group | Total | Chi-square value | p-value |
---|---|---|---|---|---|
No. of cases (%) | No. of cases (%) | N | |||
Weight gain | 13(26%) | 13(26%) | 26 | 0.000 | 1.000 |
Short stature | 3(6%) | 10(20%) | 13 | 4.332 | 0.037 |
Cataract | 4(8%) | 7(14%) | 11 | 0.919 | 0.338 |
Glaucoma | 1(2%) | 2(4%) | 3 | 0.344 | 0.558 |
Hypertension | 23(46%) | 43(86%) | 66 | 17.825 | 0.001 |
Hyperglycaemia | 1(2%) | 1(2%) | 2 | 0.000 | 1.000 |
Cushingoid facies | 26(52%) | 38(76%) | 64 | 6.250 | 0.012 |
Acanthosis | 3(6%) | 9(18%) | 12 | 3.409 | 0.065 |
Immunosuppression | 0(0%) | 2(4%) | 2 | 2.041 | 0.153 |
Gastritis | 5(10%) | 10(20%) | 15 | 1.961 | 0.262 |
Hirsutism | 6(12%) | 19(38%) | 25 | 9.013 | 0.005 |